Adaptive design for clinical trials
25 May 2010
Adaptive design for clinical trials
Preventive treatment for breast cancer
Detection and treatment of mesothelioma
Breast cancer stem cells
Metabolic pathway genes and bladder cancer risk
BMI, plasma C-peptide and smoking levels predict prostate cancer outcome
Attributable risks for hepatocellular carcinoma in the USA
Environmental tobacco smoke in relation to bladder cancer risk
Weight gain is associated with an increased risk of prostate cancer recurrence in the PSA era
Ways to predict efficacy of anthracyclines
Advances in breast cancer treatments
Targeted therapy for breast cancer